Medical/Pharmaceuticals News & Press Release Distribution

Hong Kong government endorses INDICAID(R) in visitation resumption arrangements

HONG KONG, May 11, 2021 /PRNewswire/ -- COVID-19 rapid antigen test (RAT) INDICAID®, developed by Hong Kong biotechnology start-up PHASE Scientific International Limited (PHASE), has been named by the government as one of the designated rapid tests when care homes resume visitation on Monday. The...

2021-05-11 08:00 2516

Dr Ivan Puah Reveals Why Looksmaxxing is More Than Just a Trend in Men and Its Effect

Men do get it and they know the importance of looking good. However, some become too obsessive in that pursuit, which can lead to other issues. SINGAPORE, May 11, 2021 /PRNewswire/ -- According to Dr Ivan Puah, an MOH-accredited liposuction doctor and Medical Director of Amaris B. Clinic, the...

2021-05-11 07:41 2326

Gracell Biotechnologies Appoints Seasoned Gene & Cell Therapy Executive Dr. Jenny (Yajin) Ni as Chief Technology Officer

SUZHOU and SHANGHAI, China, May 10, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced the appoin...

2021-05-11 04:01 2896

deCODE genetics - Rounding off the human genome

REYKJAVIK, Iceland, May 10, 2021 /PRNewswire/ -- In a study published today, scientists at deCODE Genetics demonstrate for the first time how long-read DNA sequencing can be applied at population scale to unravel large structural variants that associate with human disease and other traits. In...

2021-05-10 23:00 2664

deCODE genetics - Rounding off the human genome

The Firm of John Dickinson Schneider, Inc. Commemorates 100th Anniversary

LIBERTYVILLE, Ill., May 10, 2021 /PRNewswire/ -- Hollister Incorporated and KMT Medical celebrate Founder's Day today, recognizing the 100th anniversary of their parent company, The Firm of John Dickinson Schneider Inc. (JDS Inc.). A commemorative event celebrating the founder of JDS Inc.,John Di...

2021-05-10 22:00 3150

The Firm of John Dickinson Schneider, Inc. Commemorates 100th Anniversary

Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate

- Manuscript highlights development of robust responses to both influenza and COVID-19 and protection against the SARS-CoV-2 virus - Data shared via preprint server for biology, bioRxiv, ahead of publication GAITHERSBURG, Md., May 10, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechn...

2021-05-10 21:55 4686

Eurosets Lauded by Frost & Sullivan for its Integrated ECLS System, ECMOLife

Eurosets' ECMOLife device provides safe therapies for ARDS patients by minimizing the risks inherent in mechanical ventilation and for patients with severely compromised heart and lungs functions. LONDON, May 10, 2021 /PRNewswire/ -- Based on its recent analysis of the global extracorporeal memb...

2021-05-10 21:00 1674

Eurosets Lauded by Frost & Sullivan for its Integrated ECLS System, ECMOLife

DOORwaY-90 study for SIR-Spheres® therapy as first-line treatment for hepatocellular carcinoma enrolls first patient

First prospective multicenter U.S.-based trial for indication expansion of SIR-Spheres® Y-90 resin microspheres taking place in 15 sites across the U.S. WOBURN, Mass., May 10, 2021 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced that...

2021-05-10 20:30 1368

INOVIO Announces Positive Data from Phase 2 Segment of Clinical Trial Evaluating INO-4800, its COVID-19 DNA Vaccine

PLYMOUTH MEETING, Pa., May 10, 2021 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, today announced positive safety, tolerability ...

2021-05-10 20:00 4180

PharmAbcine Announces Encouraging Non-clinical Data of PMC-403 at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting

DAEJEON, South Korea, May 10, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the company presented an e-poster featuring non-clinical data of PMC-403 at the Association for Resea...

2021-05-10 20:00 1841

Thrombectomy Stroke Treatment Reversing Paralysis and Preventing Death Gets Its Global Day

The first annual "World Stroke Thrombectomy Day" is declared on May 15, 2021 by The Society of Vascular and Interventional Neurology Mission Thrombectomy 2020+ Initiative. MINNEAPOLIS, May 10, 2021 /PRNewswire/ -- The Society of Vascular and Interventional Neurology (SVIN) Mission Thrombectomy 2...

2021-05-10 20:00 1341

Viva Biotech and BioMap Reached a Strategic Collaboration Agreement, To Jointly Accelerate the Early Drug Discovery through AI Technology

SHANGHAI, May 10, 2021 /PRNewswire/ -- Hosted by BioMap and Adock, the first generation of China Biocomputing Conference was successfully launched in Suzhou. The conference is aiming to unite with biotech and IT industry partners to create a multi-party integrated industrial ecosystem, and realiz...

2021-05-10 18:21 2981

Bionomics BNC210 Expansion into Social Anxiety Disorder

* Rapid oral absorption of BNC210 novel tablet formulation ideally suited for acute treatment of anxiety in patients with Social Anxiety Disorder * BNC210 Phase 2b PTSD trial on target for start in mid-2021 with U.S. CRO Premier Research selected and clinical site identification underway * P...

2021-05-10 18:00 3721

Invitation to the presentation of Elekta's fiscal year 2020/21

STOCKHOLM, May 10, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the fiscal year 2020/21 at10:00 a.m. CEST on May 28. The year-end report will be published at 7:30 a.m. CET on the same day.The company's development will be presented by Elekta's Presid...

2021-05-10 17:43 2586

CAPA-IVM a promising advance in assisted reproduction for women with PCOS

SINGAPORE, May 10, 2021 /PRNewswire/ -- The first births and on-going well-being of babies born from an advanced assisted reproduction process called CAPA in-vitro oocyte maturation, or IVM, has highlighted the potential of the procedure for millions of women with complex fertility issues includi...

2021-05-10 13:00 2198

Hong Kong government endorses INDICAID(R) in visitation resumption arrangements

HONG KONG, May 10, 2021 /PRNewswire/ -- COVID-19 rapid antigen test (RAT) INDICAID®, developed by Hong Kong biotechnology start-up PHASE Scientific International Limited (PHASE), has been named by the government as one of the designated rapid tests when care homes resume visitation today. The end...

2021-05-10 11:30 1933

New focus on male factors critical for success in human fertility treatment

SINGAPORE, May 10, 2021 /PRNewswire/ -- The adverse impact of male factors in assisted reproductive treatments was brought into a clear and disturbing focus at the 10th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE). The ASPIRE Congress, originally to be held in the Philippine...

2021-05-10 10:06 1642

Hong Kong government endorses INDICAID(R) in visitation resumption arrangements

HONG KONG, May 10, 2021 /PRNewswire/ -- COVID-19 rapid antigen test (RAT) INDICAID®, developed by Hong Kong biotechnology start-up PHASE Scientific International Limited (PHASE), has been named by the government as one of the designated rapid tests when care homes resume visitation today. The end...

2021-05-10 10:00 2113

Hong Kong Government Endorses INDICAID® in Visitation Resumption Arrangements

HONG KONG, May 10, 2021 /PRNewswire/ -- COVID-19 rapid antigen test (RAT) INDICAID®, developed by Hong Kong biotechnology start-up PHASE Scientific International Limited (PHASE), has been named by the government as one of the designated rapid tests when care homes resume visitation today. The end...

2021-05-10 09:36 3979

Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases

SHANGHAI, May 9, 2021 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions, today announced that it has raised$60 million in its Series B fi...

2021-05-10 08:13 1818